SiSaf Ltd
SiSaf is a biopharmaceutical company developing RNA therapeutics focused on rare genetic disorders. They use bioabsorbable silicon-based Bio-Courier technology to enhance the delivery of nucleic acids for medical applications.
- RNA therapeutics
- Bio-Courier technology
- siRNA therapies for rare skeletal diseases
- Topical gene therapies for corneal dystrophies
Locations
Digital Popularity
Social Media
LinkedIn1,370 Followers
Competitors
Harness Therapeutics is focused on developing disease-modifying therapies for neurodegenerative diseases through innovative RNA translation methodologies.
Exonate is a biotechnology company dedicated to improving treatment options for patients suffering from retinal vascular diseases.
Orchard Therapeutics is a pioneering biotechnology company focused on developing transformative gene therapies for patients with severe genetic diseases.
Company Details
SiSaf Ltd is operated by Sisaf Ltd and is a Active company incorporated on 23 October 2006 with the registered office located in Guildford, Surrey. Sisaf Ltd was registered 19 years ago.
Status
Active
Size
Small
Directors
10
Age
19 years old
Employees
22
Turnover
Unreported
Total Assets
£1.91M
Cash in Bank
£1.29M
Total Liabilities
-£1.06M
Teams
20
12
4
2
4
Chairwoman & CEO • Joined Jul 2016
Non Executive Director • Joined Sep 2008
Chief Financial Officer • Joined Aug 2019
Chief A.I. Officer • Joined Jun 2023
Chief Marketing Officer
Chief Technical Officer • Joined Jul 2016
General Manager • Joined Nov 2016
EH&S Manager • Joined Jan 2023
Bioanalytical Development Manager • Joined Aug 2023
Head Of Preclinical Development • Joined Jan 2023
Chairwoman & CEO • Joined Jul 2016
Non Executive Director • Joined Sep 2008
Chief Financial Officer • Joined Aug 2019
Chief Marketing Officer
Chief Technical Officer • Joined Jul 2016
General Manager • Joined Nov 2016
EH&S Manager • Joined Jan 2023
Head Of Preclinical Development • Joined Jan 2023
Head Of Biomedical Research • Joined Aug 2023
Director, Operations & Business Development
Head Of Biomedical Research • Joined Aug 2023
Senior Formulation Chemist • Joined Jan 2024
Analytical Scientist • Joined Sep 2022
Senior Formulation Scientist • Joined Jan 2022
Chief Financial Officer • Joined Aug 2019
Bookkeeper • Joined Apr 2012
Chief A.I. Officer • Joined Jun 2023
Bioanalytical Development Manager • Joined Aug 2023
Head Of Manufacture And Supply • Joined Jan 2020
Senior Scientist - RNA Molecular Designer • Joined Feb 2023
View 20 members